DE3477469D1 - Enzyme-protein conjugate, process for its preparation and pharmaceutical use thereof - Google Patents
Enzyme-protein conjugate, process for its preparation and pharmaceutical use thereofInfo
- Publication number
- DE3477469D1 DE3477469D1 DE8484115346T DE3477469T DE3477469D1 DE 3477469 D1 DE3477469 D1 DE 3477469D1 DE 8484115346 T DE8484115346 T DE 8484115346T DE 3477469 T DE3477469 T DE 3477469T DE 3477469 D1 DE3477469 D1 DE 3477469D1
- Authority
- DE
- Germany
- Prior art keywords
- enzyme
- preparation
- pharmaceutical use
- protein conjugate
- conjugate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
- C07D213/71—Sulfur atoms to which a second hetero atom is attached
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/06—Enzymes or microbial cells immobilised on or in an organic carrier attached to the carrier via a bridging agent
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Pyridine Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB838334499A GB8334499D0 (en) | 1983-12-24 | 1983-12-24 | Derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
DE3477469D1 true DE3477469D1 (en) | 1989-05-03 |
Family
ID=10553871
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8484115346T Expired DE3477469D1 (en) | 1983-12-24 | 1984-12-13 | Enzyme-protein conjugate, process for its preparation and pharmaceutical use thereof |
DE8787115581T Expired - Fee Related DE3484655D1 (de) | 1983-12-24 | 1984-12-13 | Neue derivative. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8787115581T Expired - Fee Related DE3484655D1 (de) | 1983-12-24 | 1984-12-13 | Neue derivative. |
Country Status (12)
Country | Link |
---|---|
US (3) | US4600580A (de) |
EP (2) | EP0283563B1 (de) |
JP (1) | JPH0829085B2 (de) |
AU (1) | AU580747B2 (de) |
CA (1) | CA1271718A (de) |
DE (2) | DE3477469D1 (de) |
ES (2) | ES8609468A1 (de) |
GB (1) | GB8334499D0 (de) |
GR (1) | GR82558B (de) |
MX (1) | MX7663E (de) |
NZ (1) | NZ210696A (de) |
ZA (1) | ZA849927B (de) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5650270A (en) * | 1982-02-01 | 1997-07-22 | Northeastern University | Molecular analytical release tags and their use in chemical analysis |
GB8334498D0 (en) * | 1983-12-24 | 1984-02-01 | Beecham Group Plc | Compounds |
US4880776A (en) * | 1983-12-24 | 1989-11-14 | Beecham Group P.L.C. | Plasmin A-chain urokinase B-chain hybrid protein |
GB8334499D0 (en) * | 1983-12-24 | 1984-02-01 | Beecham Group Plc | Derivatives |
GB8400653D0 (en) * | 1984-01-11 | 1984-02-15 | Beecham Group Plc | Conjugates |
GB8430253D0 (en) * | 1984-11-30 | 1985-01-09 | Beecham Group Plc | Compounds |
US4916070A (en) * | 1986-04-14 | 1990-04-10 | The General Hospital Corporation | Fibrin-specific antibodies and method of screening for the antibodies |
GB8707369D0 (en) * | 1987-03-27 | 1987-04-29 | Beecham Group Plc | Enzyme derivatives |
US5217705A (en) * | 1987-09-25 | 1993-06-08 | Neorx Corporation | Method of diagnosing blood clots using fibrin-binding proteins |
US5151359A (en) * | 1988-05-19 | 1992-09-29 | Mitsui Toatsu Chemicals Incorporated | Method for producing of human tissue type plasminogen activator |
US5811265A (en) * | 1988-08-19 | 1998-09-22 | The General Hospital Corporation | Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use |
US5609869A (en) * | 1988-08-19 | 1997-03-11 | The General Hospital Corporation | Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use |
US5183754A (en) * | 1988-10-04 | 1993-02-02 | Mitsui Toatsu Chemicals, Incorporated | Method for production of human tissue type plasminogen activator |
US5272076A (en) * | 1991-06-13 | 1993-12-21 | Eli Lilly And Company | Compounds and methods for treatment of thromboembolic disorders using an adduct of t-PA |
US6608204B1 (en) * | 1994-12-13 | 2003-08-19 | Corvas International, Inc. | Aromatic heterocyclic derivatives as enzyme inhibitors |
CA2269335C (en) * | 1996-10-21 | 2010-05-25 | Quadrant Healthcare (Uk) Limited | Platelet substitutes and conjugation methods suitable for their preparation |
US6321909B1 (en) * | 1997-02-13 | 2001-11-27 | Sky High, Llc | System for storing polyethylene glycol solutions |
US20070041987A1 (en) * | 2003-03-19 | 2007-02-22 | Daniel Carter | Fragments or polymers of albumin with tunable vascular residence time for use in therapeutic delivery and vaccine development |
US7541159B2 (en) * | 2004-04-14 | 2009-06-02 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Molecular-specific urokinase antibodies |
US10878790B1 (en) | 2020-03-13 | 2020-12-29 | Aspire Precision Instruments, LLC | Device and method for amplitude modulated optical pickup for a stringed instrument |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US428593A (en) * | 1890-05-27 | Sleigh | ||
US4464468A (en) * | 1968-03-29 | 1984-08-07 | Agence Nationale De Valorisation De La Recherche (Anvar) | Immobilization of active protein by cross-linking to inactive protein |
GB1463513A (en) * | 1974-08-13 | 1977-02-02 | Beecham Group Ltd | Enzymes |
CS181417B1 (en) * | 1975-03-27 | 1978-03-31 | Miroslav Bleha | Method for preparing insoluble biologically active compounds |
DE2621974A1 (de) * | 1976-05-18 | 1977-11-24 | Max Planck Gesellschaft | Verfahren zur herstellung eines zur kovalenten bindung mit biologisch aktivem material befaehigten traegermaterials |
US4082612A (en) * | 1976-09-24 | 1978-04-04 | Michael Reese Research Foundation | Plasminogen activator complex |
US4134792A (en) * | 1976-12-06 | 1979-01-16 | Miles Laboratories, Inc. | Specific binding assay with an enzyme modulator as a labeling substance |
SE430062B (sv) * | 1977-03-04 | 1983-10-17 | Pharmacia Fine Chemicals Ab | Kopplings- eller tioleringsreagens |
SE427505B (sv) * | 1977-03-04 | 1983-04-11 | Pharmacia Diagnostics Ab | Reagens till anvendning vid immunkemiska bestemningsmetoder |
US4233401A (en) * | 1977-07-14 | 1980-11-11 | Syva Company | Antienzyme homogeneous competitive binding assay |
DE2862449D1 (en) * | 1977-08-22 | 1984-11-22 | Nat Res Dev | Macromolecular covalent conjugates, methods for preparing and pharmaceutical compositions containing them |
NZ191320A (en) * | 1978-09-07 | 1982-09-14 | Beecham Group Ltd | In vivo fibrinolytic enzyme having active site blocked by hydrolytically removable group pharmaceutical compositions |
SE446184B (sv) * | 1979-01-12 | 1986-08-18 | Toyo Jozo Kk | Polyfunktionell disulfidforening anvendbar som tverbindande medel |
US4305926A (en) * | 1979-09-13 | 1981-12-15 | Johannes Everse | Immobilization of Streptokinase |
US4286964A (en) * | 1979-10-12 | 1981-09-01 | Seed Brian S | Polyfunctional epoxides and halohydrins used as bridging groups to bind aromatic amine group-containing alcohols and thiols to hydroxyl bearing substrates |
FR2470773B1 (de) * | 1979-11-28 | 1983-01-28 | Pasteur Institut | |
NL8003402A (nl) * | 1980-06-11 | 1982-01-04 | Leuven Res & Dev Vzw | Nieuwe plasminogeen-activator en farmaceutisch preparaat met trombolytische werking. |
SE450834B (sv) * | 1980-11-19 | 1987-08-03 | Biocompat Inc | Sett att binda ett protein till en berare innehallande hydroxylgrupper |
SE8102193L (sv) * | 1981-04-06 | 1982-10-07 | Pharmacia Ab | Terapeutiskt aktiv organisk forening och dess anvendning |
US4429008B1 (en) * | 1981-12-10 | 1995-05-16 | Univ California | Thiol reactive liposomes |
EP0091240B1 (de) * | 1982-04-07 | 1985-12-27 | Beecham Group Plc | Enzymderivate, Verfahren zu ihrer Herstellung und dieselben enthaltende pharmazeutische Zusammensetzungen |
EP0109653A3 (de) * | 1982-11-17 | 1986-01-29 | Otsuka Pharmaceutical Co., Ltd. | Verfahren zur Herstellung eines Urokinasekomplexes |
GB8334499D0 (en) * | 1983-12-24 | 1984-02-01 | Beecham Group Plc | Derivatives |
GB8400653D0 (en) * | 1984-01-11 | 1984-02-15 | Beecham Group Plc | Conjugates |
US4542225A (en) * | 1984-08-29 | 1985-09-17 | Dana-Farber Cancer Institute, Inc. | Acid-cleavable compound |
-
1983
- 1983-12-24 GB GB838334499A patent/GB8334499D0/en active Pending
-
1984
- 1984-12-13 EP EP87115581A patent/EP0283563B1/de not_active Expired - Lifetime
- 1984-12-13 DE DE8484115346T patent/DE3477469D1/de not_active Expired
- 1984-12-13 EP EP84115346A patent/EP0155388B1/de not_active Expired
- 1984-12-13 DE DE8787115581T patent/DE3484655D1/de not_active Expired - Fee Related
- 1984-12-20 MX MX8411401U patent/MX7663E/es unknown
- 1984-12-20 ZA ZA849927A patent/ZA849927B/xx unknown
- 1984-12-21 US US06/684,359 patent/US4600580A/en not_active Expired - Fee Related
- 1984-12-21 NZ NZ210696A patent/NZ210696A/xx unknown
- 1984-12-21 AU AU37072/84A patent/AU580747B2/en not_active Ceased
- 1984-12-21 CA CA000470956A patent/CA1271718A/en not_active Expired - Fee Related
- 1984-12-21 ES ES539000A patent/ES8609468A1/es not_active Expired
- 1984-12-21 GR GR82558A patent/GR82558B/el unknown
- 1984-12-24 JP JP59272693A patent/JPH0829085B2/ja not_active Expired - Lifetime
-
1985
- 1985-09-05 ES ES546739A patent/ES8605476A1/es not_active Expired
-
1987
- 1987-04-03 US US07/034,784 patent/US4730050A/en not_active Expired - Fee Related
- 1987-04-15 US US07/039,114 patent/US4741903A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0155388A2 (de) | 1985-09-25 |
NZ210696A (en) | 1989-04-26 |
CA1271718A (en) | 1990-07-17 |
JPS60178864A (ja) | 1985-09-12 |
ES546739A0 (es) | 1986-03-16 |
GR82558B (en) | 1985-04-23 |
MX7663E (es) | 1990-06-19 |
EP0283563A3 (en) | 1988-11-23 |
EP0155388A3 (en) | 1986-12-10 |
US4600580A (en) | 1986-07-15 |
US4741903A (en) | 1988-05-03 |
EP0155388B1 (de) | 1989-03-29 |
DE3484655D1 (de) | 1991-07-04 |
EP0283563A2 (de) | 1988-09-28 |
ES8605476A1 (es) | 1986-03-16 |
ES539000A0 (es) | 1986-09-01 |
EP0283563B1 (de) | 1991-05-29 |
AU580747B2 (en) | 1989-02-02 |
ZA849927B (en) | 1986-04-30 |
AU3707284A (en) | 1985-07-04 |
JPH0829085B2 (ja) | 1996-03-27 |
GB8334499D0 (en) | 1984-02-01 |
US4730050A (en) | 1988-03-08 |
ES8609468A1 (es) | 1986-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL84863A (en) | 3-aryloxy-3-substituted propanamines,process for their preparation and pharmaceutical compositions comprising them | |
EP0299370A3 (en) | Sulphatizated hydroxy-mixed ethers, process for their preparation and their use | |
DE3477469D1 (en) | Enzyme-protein conjugate, process for its preparation and pharmaceutical use thereof | |
EP0412350A3 (en) | Renininhibitors, procedure for their preparation and use as medicaments | |
DE3265206D1 (en) | Benzazepines, process for their preparation and their application as pharmaceutical preparations | |
IL73159A0 (en) | Carboxyalkenamidocephalosporines,process for the preparation thereof and methods for the use thereof | |
EP0252286A3 (en) | Pharmaceutical preparations for topical use, process for their manufacture and their use | |
EP0187620A3 (en) | Pyrrolo-pyrroles, process for their preparation and use | |
PH22975A (en) | Substituted hydrazones, process for the preparation and their use | |
AR243499A1 (es) | Un procedimiento para la preparacion de derivados de sulfonanilida. | |
ZA844563B (en) | 13alpha-alkylgonanes,their preparation and pharmaceutical preparations containing them | |
DE3477642D1 (en) | Pulmonary surfactant, process for its preparation and its pharmaceutical use | |
CS265391A3 (en) | Novel thienodiazepines, process for their preparation and pharmaceutical comprising them | |
DE3463041D1 (en) | Tributylphenolether-glycidyl-sulphonates, process for their preparation and their use | |
ZA83592B (en) | Corynantheine derivatives,processes for their preparation,and their use | |
IL74133A0 (en) | Azolyl-aryl-alkanol derivatives,processes for their preparation and their use | |
DE3364376D1 (en) | Isoindolazines, process for their preparation and their use | |
EP0121081A3 (en) | Azolylmethylcycloalkanes, process for their preparation and their therapeutical use | |
ZA846580B (en) | 16-fluoro-16,17-didehydro-prostanoids and process for their preparation | |
EP0270682A4 (de) | Neue komplexe deren herstellung und verwendung als arzneimittel. | |
ZA871756B (en) | Arylazolylmethylbenzocycloalkene derivatives,processes for the preparation thereof,and the use thereof | |
EP0418020A3 (en) | Cephalosporinderivatives, process for their preparation and pharmaceutical compositions | |
DE3264284D1 (en) | Bisimidazolines, process for their preparation and their use | |
EP0172919A4 (de) | Cephalosporinabkömmlinge, deren herstellungsverfahren und deren verwendung als arzneimittel. | |
ZW12286A1 (en) | New benzamides,process for their preparation and their application in the pharmaceutical field |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |